Pancreatic Cancer Research

ResearcherHarbin Medical UniversityNo recent work listed

Dan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3814-7556; OpenAlex author ID A5100411814. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Sodium channel 1 subunit alpha SCNN1A exerts oncogenic function in pancreatic cancer via accelerating cellular growth and metastasis. First author DOI 10.1016/j.abb.2022.109323↗
  2. Lower Mean Corpuscular Hemoglobin Concentration is Associated with Favorable Prognosis of Resected Pancreatic Cancer. Co-author DOI 10.21203/rs.3.rs-109365/v1↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shaolong Sun · 1 shared paper, 2022 · strength 0.19
  2. Feng Gao · 1 shared paper, 2022 · strength 0.19
  3. Yunhao Wu · 1 shared paper, 2022 · strength 0.19
  4. Xiaona Fan · 1 shared paper, 2020 · strength 0.11
  5. Zhiwei Li · 1 shared paper, 2020 · strength 0.11
  6. Lin Fang · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.